Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 50 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 71 | 2,940−4.2%/yr | −4.2%/yr | 3.31.0× | 5% | 3,010 in 2030+0.4%/yr |
| Lumbar fusion | 58 | 2,364−2.2%/yr | −2.2%/yr | 2.60.8× | 5% | 2,480 in 2030+0.8%/yr |
| Cervical fusion & disc arthroplasty | 34 | 1,470−1.4%/yr | −1.4%/yr | 1.61.0× | 5% | 1,510 in 2030+0.4%/yr |
| Kyphoplasty & vertebroplasty | 8 | 809+0.7%/yr | +0.7%/yr | 0.90.5× | 57% | 730 in 2030−1.6%/yr |
| SI joint fusion | 2 | 164+22%/yr | +22%/yr | 0.20.5× | 0% | 290 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 326 | 74,510−0.7%/yr | −0.7%/yr | 82.40.7× | 45% | 93,400 in 2030+3.8%/yr |
| Skin substitutes & wound grafts | 25 | 5,850+12%/yr | +12%/yr | 5.30.5× | 70% | 12,200 in 2030+13%/yr |
| Bone graft & orthobiologics | 14 | 451−8%/yr | −8%/yr | 0.50.7× | 4% | 370 in 2030−3.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 110 | 8,602−0.5%/yr | −0.5%/yr | 9.50.7× | 97% | 8,640 in 2030+0.1%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 12 | 704+23%/yr | +23%/yr | 0.80.5× | 89% | 1,180 in 2030+9%/yr |
| Spinal cord & DRG stimulation | 13 | 599+6.8%/yr | +6.8%/yr | 0.70.7× | 87% | 820 in 2030+5.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 52 | 6,992−4.8%/yr | −4.8%/yr | 7.71.2× | 84% | 8,070 in 2030+2.4%/yr |
| Dialysis access | 40 | 4,421−11%/yr | −11%/yr | 5.10.9× | 64% | 4,640 in 2030+0.8%/yr |
| Superficial venous ablation | 43 | 3,848−12%/yr | −12%/yr | 4.30.7× | 100% | 3,720 in 2030−0.6%/yr |
| Thrombectomy, IVC filters & venous stents | 20 | 1,433−0.5%/yr | −0.5%/yr | 1.60.9× | 45% | 1,430 in 20300%/yr |
| Carotid revascularization | 19 | 887+1.4%/yr | +1.4%/yr | 1.00.8× | 0% | 950 in 2030+1.2%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 330−2.9%/yr | −2.9%/yr | 0.40.8× | 0% | 400 in 2030+3.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 60 | 4,436+0.2%/yr | +0.2%/yr | 5.20.8× | 9% | 5,200 in 2030+2.7%/yr |
| Cholecystectomy & appendectomy | 54 | 2,461−3.8%/yr | −3.8%/yr | 2.80.6× | 6% | 2,750 in 2030+1.9%/yr |
| Colorectal resection | 9 | 1,152−4.6%/yr | −4.6%/yr | 1.30.8× | 0% | 1,300 in 2030+2.1%/yr |
| Breast reconstruction | 1 | 439−4.8%/yr | −4.8%/yr | 0.51.0× | 0% | 540 in 2030+3.5%/yr |
| Antireflux & hiatal hernia surgery | 9 | 381−0.3%/yr | −0.3%/yr | 0.40.5× | 0% | 520 in 2030+5.3%/yr |
| Bariatric surgery | 1 | 118−17%/yr | −17%/yr | 0.10.7× | 0% | 30 in 2030−20%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 65 | 4,904−8.2%/yr | −8.2%/yr | 5.51.1× | 82% | 4,770 in 2030−0.5%/yr |
| Kidney stone management | 91 | 3,844−0.6%/yr | −0.6%/yr | 4.40.9× | 68% | 4,210 in 2030+1.5%/yr |
| Hysterectomy, hysteroscopy & ablation | 37 | 2,575−1.2%/yr | −1.2%/yr | 3.11.2× | 16% | 2,650 in 2030+0.5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 35 | 1,684+0.8%/yr | +0.8%/yr | 1.90.7× | 34% | 1,910 in 2030+2.1%/yr |
| Prostatectomy & nephrectomy | 15 | 867−3.9%/yr | −3.9%/yr | 1.00.8× | 0% | 990 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 29 | 2,344−4.8%/yr | −4.8%/yr | 2.70.5× | 95% | 1,970 in 2030−2.8%/yr |
| Ear tubes & middle ear surgery | 2 | 181−4.3%/yr | −4.3%/yr | 0.20.6× | 100% | 100 in 2030−10%/yr |
| Cochlear implants | 4 | 116+2.8%/yr | +2.8%/yr | 0.10.8× | 0% | 100 in 2030−2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 79 | 5,089−2.2%/yr | −2.2%/yr | 6.00.9× | 73% | 5,630 in 2030+1.7%/yr |
| Tumor & fibroid embolization | 12 | 701+17%/yr | +17%/yr | 0.81.4× | 80% | 1,270 in 2030+10%/yr |
| Tumor ablation | 5 | 276+7%/yr | +7%/yr | 0.31.0× | 0% | 670 in 2030+16%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 171 | 26,549+30%/yr | +30%/yr | 29.81.1× | 87% | 49,300 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 50 | 3,380−1.5%/yr | −1.5%/yr | 3.90.7× | 1% | 3,330 in 2030−0.2%/yr |
| EP ablation | 43 | 2,173+8.6%/yr | +8.6%/yr | 2.30.6× | 0% | 3,610 in 2030+8.8%/yr |
| LAA occlusion & loop recorders | 56 | 1,696+8.1%/yr | +8.1%/yr | 1.80.5× | 35% | 3,080 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 71 | 3,197−5.6%/yr | −5.6%/yr | 3.30.5× | 0% | 4,090 in 2030+4.2%/yr |
| Structural heart (TAVR, TEER) | 45 | 1,095+6.5%/yr | +6.5%/yr | 1.10.7× | 0% | 1,750 in 2030+8.1%/yr |
| Mechanical circulatory support | 5 | 360−2%/yr | −2%/yr | 0.40.7× | 0% | 350 in 2030−0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 10 | 326+15%/yr | +15%/yr | 0.40.8× | 0% | 570 in 2030+9.9%/yr |
| Stroke thrombectomy | 13 | 289+7.1%/yr | +7.1%/yr | 0.30.8× | 0% | 580 in 2030+12%/yr |
| CSF shunts | 3 | 162−5.9%/yr | −5.9%/yr | 0.21.0× | 0% | 150 in 2030−1.2%/yr |
| DBS & VNS | 1 | 111−4.1%/yr | −4.1%/yr | 0.10.4× | 0% | 120 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 198 | 39,250−1.2%/yr | −1.2%/yr | 44.00.7× | 91% | 41,300 in 2030+0.8%/yr |
| Vitreoretinal surgery | 30 | 2,121−7.2%/yr | −7.2%/yr | 2.40.9× | 26% | 2,290 in 2030+1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 357 | 91,101−2.7%/yr | −2.7%/yr | 105.10.9× | 65% | 97,500 in 2030+1.1%/yr |
| Bronchoscopy & lung nodule | 33 | 2,509+4.4%/yr | +4.4%/yr | 2.90.9× | 1% | 3,560 in 2030+6%/yr |
| ERCP & endoscopic ultrasound | 36 | 2,499+2.9%/yr | +2.9%/yr | 2.90.9× | 1% | 3,770 in 2030+7.1%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.